<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:26:06Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8235654" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8235654</identifier>
        <datestamp>2021-06-27</datestamp>
        <setSpec>nutrients</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Nutrients</journal-id>
              <journal-id journal-id-type="iso-abbrev">Nutrients</journal-id>
              <journal-id journal-id-type="publisher-id">nutrients</journal-id>
              <journal-title-group>
                <journal-title>Nutrients</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2072-6643</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8235654</article-id>
              <article-id pub-id-type="pmcid">PMC8235654</article-id>
              <article-id pub-id-type="pmc-uid">8235654</article-id>
              <article-id pub-id-type="pmid">34207221</article-id>
              <article-id pub-id-type="pmid">34207221</article-id>
              <article-id pub-id-type="doi">10.3390/nu13062088</article-id>
              <article-id pub-id-type="publisher-id">nutrients-13-02088</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Impact of Dairy Intake on Plasma F<sub>2</sub>-IsoProstane Profiles in Overweight Subjects with Hyperinsulinemia: A Randomized Crossover Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Khorraminezhad</surname>
                    <given-names>Leila</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-nutrients-13-02088">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bilodeau</surname>
                    <given-names>Jean-François</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-nutrients-13-02088">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Greffard</surname>
                    <given-names>Karine</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-nutrients-13-02088">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Larose</surname>
                    <given-names>Jessica</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-nutrients-13-02088">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rudkowska</surname>
                    <given-names>Iwona</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-nutrients-13-02088">1</xref>
                  <xref rid="c1-nutrients-13-02088" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Michaëlsson</surname>
                    <given-names>Karl</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-nutrients-13-02088"><label>1</label>Endocrinology and Nephrology Unit, CHU de Québec-Laval University Research Center, CHUL-2705, Quebec City, QC G1V 4G2, Canada; <email>Leila.khorraminezhad.1@ulaval.ca</email> (L.K.); <email>Karine.Greffard@crchudequebec.ulaval.ca</email> (K.G.); <email>Jessica.Larose@crchudequebec.ulaval.ca</email> (J.L.)</aff>
              <aff id="af2-nutrients-13-02088"><label>2</label>Department of Medicine, Laval University, Quebec City, QC G1V 4G2, Canada; <email>Jean-Francois.Bilodeau@crchudequebec.ulaval.ca</email></aff>
              <author-notes>
                <corresp id="c1-nutrients-13-02088"><label>*</label>Correspondence: <email>iwona.rudkowska@crchudequebec.ulaval.ca</email>; Tel.: +1-418-525-4444 (ext. 46380)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>18</day>
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <volume>13</volume>
              <issue>6</issue>
              <elocation-id>2088</elocation-id>
              <history>
                <date date-type="received">
                  <day>17</day>
                  <month>4</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>11</day>
                  <month>6</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 by the authors.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>F<sub>2</sub>-IsoProstanes (F<sub>2</sub>-IsoPs) are major biomarkers of oxidative stress and are associated with type 2 diabetes (T2D). Further, plasma levels of F<sub>2</sub>-IsoPs may be modified by dairy products. The aim is to investigate the effect of high dairy product (HD) consumption compared to an adequate dairy product (AD) consumption on the level of F<sub>2</sub>-IsoPs among hyperinsulinemic subjects. In this crossover study, participants were randomized in two groups: HD (≥4 servings/day), or AD (≤2 servings/day) for six weeks. Fasting blood glucose and insulin were measured. The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated. Six isomers of F<sub>2</sub>-IsoPs were quantified by HPLC-MS/MS. Twenty-seven subjects with hyperinsulinemia (mean age; 55 ± 13 years, BMI; 31.4 ± 3.3 kg/m2) were included. Fasting glucose, insulin and HOMA-IR were unchanged after HD or AD intervention. After HD intake, the total level of F<sub>2</sub>-IsoPs (<italic>p</italic> = 0.03), 5-F<sub>2<italic>t</italic></sub>-IsoP (<italic>p</italic> = 0.002), and 8-F<sub>2<italic>t</italic></sub>-IsoP (<italic>p</italic> = 0.004) decreased compared to AD. The 15-F<sub>2t</sub>-IsoP tended to be positively correlated with fasting blood glucose (<italic>r</italic> = 0.39, <italic>p</italic> = 0.08). Generally, F<sub>2</sub>-IsoPs levels were higher among men compared to women regardless of the dairy intake. Overall, intake of HD decreased plasma levels of F<sub>2</sub>-IsoPs compared to AD without modifying glycemic parameters.</p>
              </abstract>
              <kwd-group>
                <kwd>F<sub>2</sub>-isoprostane</kwd>
                <kwd>dairy products</kwd>
                <kwd>type 2 diabetes</kwd>
                <kwd>hyperinsulinemia</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-nutrients-13-02088">
              <title>1. Introduction</title>
              <p>F<sub>2</sub>-isoprostanes (F<sub>2</sub>-IsoPs) are prostaglandin-like compounds produced from the oxidation of polyunsaturated fatty acids (PUFA) like arachidonic acid (AA) [<xref rid="B1-nutrients-13-02088" ref-type="bibr">1</xref>]. F<sub>2</sub>-IsoPs are used as gold standard markers for the assessment of oxidative stress [<xref rid="B2-nutrients-13-02088" ref-type="bibr">2</xref>]. Isoprostanes (IsoPs) can be generated in phospholipids by free radicals and are subsequently released from cell membranes by phospholipases [<xref rid="B3-nutrients-13-02088" ref-type="bibr">3</xref>]. Generally, F<sub>2</sub>-IsoPs are associated with atherogenesis and inflammation. F<sub>2</sub>-IsoPs are believed to act through impairment of glycemic homeostasis [<xref rid="B3-nutrients-13-02088" ref-type="bibr">3</xref>], stimulation of proliferative responses in fibroblasts [<xref rid="B4-nutrients-13-02088" ref-type="bibr">4</xref>] and alterations of membrane lipids [<xref rid="B5-nutrients-13-02088" ref-type="bibr">5</xref>].</p>
              <p>The level of plasma F<sub>2</sub>-IsoP has been recognized as one of the major biomarkers associated with the pathogenesis of type 2 diabetes (T2D) [<xref rid="B4-nutrients-13-02088" ref-type="bibr">4</xref>]. F<sub>2</sub>-IsoPs have been implicated in the impairment of beta-cell functions and have been shown to induce apoptosis through the peroxidation of membrane cholesterol [<xref rid="B6-nutrients-13-02088" ref-type="bibr">6</xref>]. Moreover, observational and clinical studies confirmed an increase in total levels of F<sub>2</sub>-IsoPs, specifically the 15-F<sub>2t</sub>-IsoP, also known as the classical 8-iso-PGF<sub>2a</sub>, among diabetic patients in comparison to nondiabetic [<xref rid="B3-nutrients-13-02088" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-13-02088" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-13-02088" ref-type="bibr">5</xref>,<xref rid="B6-nutrients-13-02088" ref-type="bibr">6</xref>] and healthy overweight adults [<xref rid="B7-nutrients-13-02088" ref-type="bibr">7</xref>]. Overall, F<sub>2</sub>-IsoPs are associated with major inflammatory parameters that determine the incidence of T2D among obese populations [<xref rid="B2-nutrients-13-02088" ref-type="bibr">2</xref>].</p>
              <p>Dietary intake, specifically of dairy products, could contribute to the prevention of oxidative stress and an adequate glycemic response through micronutrient effects such as calcium and vitamin D. For instance, a randomized-parallel-group study indicated a reduction in plasma level of 15-F2t-IsoP after intake of adequate-dairy (3.5 servings/d and ≥1000 mg calcium/d) compared to low-dairy (&lt;0.5 daily servings and ≤600 mg calcium/d) during a 12-week intervention in obese adults with metabolic syndrome [<xref rid="B8-nutrients-13-02088" ref-type="bibr">8</xref>]. However, a 6-month randomized, parallel-group intervention study demonstrated no change in the plasma level of 15-F2t-IsoP after consumption of three to five milk servings per day compared to the control group (0.5–1 serving/d) among overweight men and women [<xref rid="B9-nutrients-13-02088" ref-type="bibr">9</xref>]. Despite indirect evidence of the potential role of dairy products on oxidative stress and glycemic parameters, the association between T2D risk factors and F2-IsoPs after dairy product intake remains unknown in overweight individuals with hyperinsulinemia.</p>
              <p>Thus, the hypothesis of this study is that the level of F<sub>2</sub>-IsoPs are modified after consumption of high dairy (HD (≥4 servings/day)) products compared with consumption of adequate dairy (AD (≤2 servings/day)) products. The secondary hypothesis is that variations in the levels of F<sub>2</sub>-IsoPs are correlated with changes in glycemic parameters among subjects with hyperinsulinemia.</p>
            </sec>
            <sec id="sec2-nutrients-13-02088">
              <title>2. Materials and Methods</title>
              <sec id="sec2dot1-nutrients-13-02088" sec-type="subjects">
                <title>2.1. Participants</title>
                <p>This randomized crossover study included 27 individuals (19 men and 8 women) aged between 28 and 71 years who were assessed at the CHU de Québec-Université Laval Research Center from February 2017 to July 2018. All subjects were Caucasian men and postmenopausal women (absence of menstrual cycles for &gt;12 months) aged &gt;18 yrs, BMI between 25–40 kg/m2 (overweight, 25 ≤ BMI ≤ 29.9 kg/m<sup>2</sup> or obesity, BMI ≥ 30 kg/m<sup>2</sup>), had hyperinsulinemia and selected based on fasting insulin &gt; 90 pmol/L, fasting glucose &lt; 7.0 mmol/L and glycated hemoglobin (HbA1c) &lt; 6.5%. Furthermore, exclusion criteria were the same as in the previously published study [<xref rid="B10-nutrients-13-02088" ref-type="bibr">10</xref>], including high dairy consumption (≥2 servings/day), major surgery in the three months prior to study onset, smoking, incompatibility with dairy consumption (allergy, intolerance or dislike), inflammatory bowel disease or other gastrointestinal disorder influencing gastrointestinal motility or nutrient absorption, medications known to affect lipid and glucose metabolism other than those used to treat hypertension or dyslipidemia and diseases known to affect glucose metabolism.</p>
                <p>This study was approved by the CHU de Québec-Université Laval Research Center ethics committees (permission code: 2017-3228) and was conducted according to the principles of the declaration of Helsinki. All subjects provided written informed consent. This trial protocol is registered in ClinicalTrial.gov: NCT02961179. Subjects deemed eligible through a telephone screening process were invited for a screening visit where demographic, medical and food frequency questionnaires were administered.</p>
              </sec>
              <sec id="sec2dot2-nutrients-13-02088">
                <title>2.2. Dietary Intervention</title>
                <p>Participants were equally randomized to HD (n = 12) or AD (n = 15). After the first intervention phase (6-week) and a 6-week washout period, subjects crossed over to the other phase (6-week). During the HD intervention period, subjects consumed ≥4 servings/day of dairy products and during the AD intervention period, they consumed ≤2 servings/day of dairy products (according to the serving sizes recommended by Canada’s Food Guide for Healthy Eating (2007) [<xref rid="B11-nutrients-13-02088" ref-type="bibr">11</xref>]). All subjects were requested to keep the same physical activity, eating habits and other aspects of lifestyle during the study. Dairy products comprised milk, yogurt, cheese, kefir and cream (≤15% fat content). Ice cream intake (1 serving equals 125 mL) was limited to three servings per week. Butter, milk substitutes and derivatives, whipped cream or cream &gt;15% fat content, and soy desserts or plant-based beverages (almond, cashew, rice, hemp, etc.) were not accepted as dairy products in the daily serving count. Dietary information was collected at each visit by using a validated autoadministered food frequency questionnaire (FFQ) containing 91 items and 33 subquestions that were completed through a web platform linked to the Nutrition Data System for Research [<xref rid="B12-nutrients-13-02088" ref-type="bibr">12</xref>]. Dietary intake was estimated using the Canadian Nutrient File 2015 [<xref rid="B11-nutrients-13-02088" ref-type="bibr">11</xref>].</p>
              </sec>
              <sec id="sec2dot3-nutrients-13-02088">
                <title>2.3. Anthropometric Assessments</title>
                <p>For all participants in the study, weight (kg) and height (cm) were measured. Body weight was measured with a professional scale accurate to 0.1 kg (Health O Meter Professional, Sunbeam products, Inc., Boca Raton, FL, USA), and height was measured using a wall-mounted stadiometer with 1 mm accuracy (The Easy-Glide Bearing Stadiometer, Perspective Enterprises), with subjects in light clothing and without shoes. Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared and recorded as kg/m<sup>2</sup>. Blood pressure was measured following a 15-min rest on a chair by using the SphygmoCor XCEL system. Body fat mass was evaluated in the fasting state and at the same time across visits using a 4-electrode bioimpedance scale (InBody 520 Body Composition Analyzer).</p>
              </sec>
              <sec id="sec2dot4-nutrients-13-02088">
                <title>2.4. Clinical Measurements</title>
                <p>Visits were scheduled at the beginning and at the end of each intervention period, which represented a total of four visits separated by six week intervals. Fasting blood glucose (FBG) levels were measured using hexokinase assays [<xref rid="B13-nutrients-13-02088" ref-type="bibr">13</xref>]. Blood fasting insulin levels were measured with chemiluminescence immunoassays [<xref rid="B14-nutrients-13-02088" ref-type="bibr">14</xref>]. Insulin resistance was estimated using the HOMA-IR index: HOMA-IR = [insulin (pmol/L) × glucose (mmol/L)]/135 [<xref rid="B15-nutrients-13-02088" ref-type="bibr">15</xref>]. Plasma total cholesterol (TC) and triglycerides (TG) concentrations were measured using enzymatic assays [<xref rid="B16-nutrients-13-02088" ref-type="bibr">16</xref>,<xref rid="B17-nutrients-13-02088" ref-type="bibr">17</xref>]. The HDL cholesterol (HDL-C) fraction was obtained after precipitation of very low-density lipoprotein and LDL particles in the infranatant with heparin manganese chloride [<xref rid="B18-nutrients-13-02088" ref-type="bibr">18</xref>]. LDL cholesterol (LDL-C) was calculated with the Friedewald formula [<xref rid="B19-nutrients-13-02088" ref-type="bibr">19</xref>]. HbA1c was determined using a colorimetric method after an initial separation by ion exchange chromatography [<xref rid="B20-nutrients-13-02088" ref-type="bibr">20</xref>].</p>
              </sec>
              <sec id="sec2dot5-nutrients-13-02088">
                <title>2.5. Measurements of Plasma Level of F<sub>2</sub>-IsoPs</title>
                <p>Total F<sub>2</sub>-IsoPs and its isomers, including 5(<italic>RS</italic>)-5-F<sub>2c</sub>-IsoP, 5-<italic>epi</italic>-5-F<sub>2t</sub>-IsoP, 5-F<sub>2t</sub>-IsoP, 8-F<sub>2t</sub>-IsoP, 15-<italic>epi</italic>-15-F<sub>2t</sub>-IsoP and 15-F<sub>2t</sub>-IsoP were measured in plasma from a modified previous method [<xref rid="B21-nutrients-13-02088" ref-type="bibr">21</xref>]. Briefly, 750 µL of plasma were mixed with 250 µL of water and 10 µL of deuterated internal standards (25 ng of deuterated standard in ethanol). Alkaline hydrolysis was performed by adding 985 µL of potassium hydroxide (1 M in methanol) for 1 h at 37 °C. Water (1 mL) was further added to the sample before proceeding to a solid phase extraction (SPE) with Oasis MAX 60 mg/3 cc cartridge from Waters Corporation (Mississauga, ON, Canada). Briefly, samples were loaded on SPE cartridges conditioned with methanol and water. Consecutive washes were made with sodium acetate buffer (50 mM, pH 3), n-hexane, ammonium hydroxide (2.5 mM), and finally with an acetonitrile-methanol mixture (8:2 <italic>v</italic>/<italic>v</italic>). The F<sub>2</sub>-IsoPs were eluted with a mix of 79.2% of acetonitrile, 19.8% methanol and 1% acetic acid and then dried under a nitrogen stream. Samples were reconstituted with 60 μL of 30% acetonitrile-0.01% acetic acid. The same procedure was used to build a calibration curve in plasma. The analysis was carried out on a Shimadzu Prominence HPLC (Columbia, MD, USA) coupled to a 3200 QTRAP<sup>®</sup> MS/MS from AB Sciex (Concord, ON, Canada) configured with a Turbo V™ electrospray ionization probe operated in negative mode. Chromatographic separation of injected samples (40 µL) was achieved on a Kinetex C18 100 Å column from Phenomenex (Torrance, CA, USA) with a ternary mobile phase gradient described elsewhere [<xref rid="B22-nutrients-13-02088" ref-type="bibr">22</xref>]. Acquisition with Analyst 1.7 was performed in the multiple reactions monitoring mode and quantification was achieved by using SCIEX OS 1.7MQ software (AB Sciex).</p>
              </sec>
              <sec id="sec2dot6-nutrients-13-02088">
                <title>2.6. Statistical Analyses</title>
                <p>Statistical analyses were performed using IBM SPSS statistics software for macOS version 27.0.1.0 (IBM Corp. Armonk, (NY) the USA). The charts were generated by GraphPad Prism version 9 for macOS. Before performing statistical analyses, the Shapiro–Wilk test was examined to evaluate the normality of the data distribution The difference in IsoPs levels at the beginning of each phase between AD and HD was examined by an independent sample <italic>t</italic>-test. The generalized linear mixed model (GLMM) was performed with repeated measures (visit) and compound symmetry as a repeated covariance structure that minimizes the Akaike criterion. A collinearity test was conducted revealing collinearity between BMI and energy intake (<italic>p</italic> = 0.03). Therefore, the fixed effects in GLMM analysis were intervention (HD, AD), visit number (V2, V4), sequence (AD/HD, HD/AD), sex and BMI. The subject was considered as a random effect. Robust estimation was used to handle the violation of model assumptions. Multiple comparisons were adjusted using sequential Bonferroni. Bivariate and partial correlations (adjusted for sex and BMI) were applied to examine the quantitative relationship between IsoPs levels and glycemic profile (FBG, fasting blood insulin, HOMA-IR).Data are expressed as arithmetic means ± SD unless otherwise stated. A <italic>p</italic>-value of less than 0.05 was considered significant for all statistics, and a <italic>p</italic>-value of between 0.05 and 0.1 was considered a tendency.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-nutrients-13-02088">
              <title>3. Results</title>
              <sec id="sec3dot1-nutrients-13-02088">
                <title>3.1. Descriptive Results of Rarticipants</title>
                <p>The study flow diagram is published in the previous study (<xref ref-type="app" rid="app1-nutrients-13-02088">Supplementary Figure S1</xref>) [<xref rid="B10-nutrients-13-02088" ref-type="bibr">10</xref>]. This crossover study included 27 subjects with hyperinsulinemia (2 h glucose post-OGTT ≥7.8 mmol/L and/or FBG ≥6.1 mmol/L) of both sexes (8 women, 19 men). The characteristics of participants are presented in <xref rid="nutrients-13-02088-t001" ref-type="table">Table 1</xref>. The baseline means of age, BMI, weight, height and HbA1c of all participants were 55 ± 13 years, 31.4 ± 3.3 kg/m<sup>2</sup>, 90.33 ± 14.77 kg, 1.69 ± 0.09 m, and 5.58 ± 0.29 %, respectively. Participants were categorized as overweight (7 subjects, 25 ≤ BMI ≤ 29.9 kg/m<sup>2</sup>) and obese (20 subjects) group (BMI ≥ 30 kg/m<sup>2</sup>). GLMM analysis indicated that after intake of HD, the level of anthropometric characteristics, glycemic parameters (FBG, fasting blood insulin, HOMA-IR) and lipid profiles (LDL, HDL, TG, Chol) were unchanged compared to AD consumption.</p>
              </sec>
              <sec id="sec3dot2-nutrients-13-02088">
                <title>3.2. Dietary Intake</title>
                <p>Dietary intakes from FFQ are presented in <xref rid="nutrients-13-02088-t002" ref-type="table">Table 2</xref>. The mean of dairy products consumption after AD compared with HD was 2.4 ± 1.2 and 5.8 ± 2.1 servings/d, respectively. The portions intake of milk (0.77 ± 0.72 compared to 2.43 ± 1.41, <italic>p</italic> &lt; 0.001(AD vs. HD, respectively)), cheese (fatty-cheese and nonfatty cheese) (0.80 ± 0.80 compared to 1.94 ± 1.04, <italic>p</italic> &lt; 0.001), yogurt (0.31 ± 0.42 compared to 1.49 ± 1.52, <italic>p</italic> &lt; 0.001), liquid dairy products (1.21 ± 0.79 compared to 4.19 ± 1.95, <italic>p</italic> &lt; 0.001), low-fat dairy (1.11 ± 0.89 compared to 3.65 ± 2.13, <italic>p</italic> &lt; 0.001), and fermented dairy (1.07 ± 0.896 compared to 3.18 ± 1.59, <italic>p</italic> &lt; 0.001) were higher after HD compared to AD.</p>
                <p>Furthermore, GLMM analysis demonstrated that total energy intake (<italic>p</italic> = 0.01), total intake of macronutrient including carbohydrate (<italic>p</italic> = 0.04), protein (<italic>p</italic> = 0.001), fat (<italic>p</italic> = 0.01), and saturated fat (<italic>p</italic> = 0.002) were significantly higher after HD compared to AD. However, estimated consumption of AA, eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA) as primary precursors in the synthesis of IsoPs remained unchanged after HD intervention compared to AD intervention (<italic>p</italic> &gt; 0.05).</p>
              </sec>
              <sec id="sec3dot3-nutrients-13-02088">
                <title>3.3. Isomers of F<sub>2</sub>-IsoPs</title>
                <p>No difference was found in the level of total F<sub>2</sub>-IsoPs and isomers of F<sub>2</sub>-IsoPs at the beginning of each phase by independent sample <italic>t</italic>-test (<italic>p</italic> &gt; 0.05) (<xref ref-type="app" rid="app1-nutrients-13-02088">Table S1</xref>). Several isomers of F<sub>2</sub>-IsoPs, including 5(<italic>RS</italic>)-5-F<sub>2c</sub>-IsoP, 5-<italic>epi</italic>-5-F<sub>2t</sub>-IsoP, 5-F<sub>2t</sub>-IsoP, 8-F<sub>2t</sub>-IsoP, 15-<italic>epi</italic>-15-F<sub>2t</sub>-IsoP and 15-F<sub>2t</sub>-IsoP were measured after HD and AD consumption (<xref ref-type="fig" rid="nutrients-13-02088-f001">Figure 1</xref>). Using paired <italic>t</italic>-test, a significant lower plasma levels of both, 5-F<sub>2t</sub>-IsoP (-21%; <italic>p</italic> = 0.003) and 8-F<sub>2t</sub>-IsoP (−16%; <italic>p</italic> = 0.008) after consumption of HD compared to AD were observed (<xref ref-type="fig" rid="nutrients-13-02088-f001">Figure 1</xref>). Furthermore, changes in the level of isoprostane during AD and HD phases were indicated in the <xref ref-type="app" rid="app1-nutrients-13-02088">Table S2</xref>. There was no significant difference in the changes of IsoPs level between AD and HD phases. Due to the effect of energy intake on IsoPs levels in previous studies, we examined the correlation between energy intake and IsoPs levels in each phase; there were no correlation between energy intake and IsoPs levels in present study.</p>
                <p>GLMM analysis that took into account BMI and sex showed that after HD intake the total levels of F<sub>2</sub>-IsoP (<italic>p</italic> = 0.03, −11%), 5-F<sub>2t</sub>-IsoP (<italic>p</italic> = 0.002, −16%) and 8-F<sub>2t</sub>-IsoP (<italic>p</italic> = 0.004, −15%) were lower in comparison to AD (<xref rid="nutrients-13-02088-t003" ref-type="table">Table 3</xref>; <xref ref-type="fig" rid="nutrients-13-02088-f002">Figure 2</xref>).</p>
                <p>Of note, there was no effect of age and energy intake on isoprostane levels in GLMM analyses; therefore, sex and BMI were considered as fixed effect parameters. Most F<sub>2</sub>-IsoPs isomers were affected by the sex of the participant except for the 15-F<sub>2t</sub>-IsoP. Indeed, a higher level of F<sub>2</sub>-IsoPs isomers in men than women was observed in general (<xref ref-type="fig" rid="nutrients-13-02088-f002">Figure 2</xref>).</p>
                <p>Moreover, no carry-over effects were found in the study, since the sequence of the treatment remained nonsignificant (<xref rid="nutrients-13-02088-t003" ref-type="table">Table 3</xref>). Of note, no correlation was found between isomers of F<sub>2</sub>-IsoPs and glycemic profile (FBG, fasting blood inulin, HOMA-IR) after AD and HD intervention. Furthermore, after adjusting for age, sex and BMI in AD intervention, the 15-F<sub>2t</sub>-IsoP tended to be positively correlated with FBG (<italic>p</italic> = 0.08; <italic>r</italic> = 0.39; <xref ref-type="app" rid="app1-nutrients-13-02088">Tables S3 and S4</xref>).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-nutrients-13-02088">
              <title>4. Discussion</title>
              <p>The present study demonstrates for the first time that the consumption of HD decreases the total level of F<sub>2</sub>-IsoP, 5-F<sub>2t</sub>-IsoP, and 8-F<sub>2t</sub>-IsoP compared to consumption of AD. Specifically, the 5-F<sub>2t</sub>-IsoP and 8-F<sub>2t</sub>-IsoP were reduced by HD intake. Most previous studies investigated only the 15-F<sub>2t</sub>-IsoP. Moreover, 15-F<sub>2t</sub>-IsoP was positively correlated with FBG after AD consumption. These results also demonstrate the need to assess several isomers of F<sub>2</sub>-IsoP to obtain an overview of oxidative effects. The specific isomers affected can differ with pathologies. The previous study showed that 5-F<sub>2t</sub>-IsoP/5-epi-F<sub>2t</sub>-IsoP were associated with hypertension during pregnancy and proteinuria [<xref rid="B23-nutrients-13-02088" ref-type="bibr">23</xref>], while 15-<italic>epi</italic>-15-F<sub>2<italic>t</italic></sub>-IsoP was associated with diabetes in pregnancy [<xref rid="B24-nutrients-13-02088" ref-type="bibr">24</xref>]. Moreover, plasma levels of F<sub>2</sub>-IsoP were lower among women compared to men after HD consumption compared to AD.</p>
              <p>Generally, the level of F<sub>2</sub>-IsoPs was lower after consumption of HD compared to AD, especially the total level of F<sub>2</sub>-IsoP, 5-F<sub>2t</sub>-IsoP, 8-F<sub>2t</sub>-IsoP, and 15-F<sub>2t</sub>-IsoP. Similarly, the plasma levels of 15-F<sub>2t</sub>-IsoP and tumor necrosis factor-alpha (TNF-alpha) were reduced after the intake of 1200-1400 mg calcium/d (three servings/d dairy products and 1050 mg calcium/d) compared with 400-500 mg calcium/d (soy-supplementation) during a four-week period in obese or overweight subjects [<xref rid="B5-nutrients-13-02088" ref-type="bibr">5</xref>]. However, no difference in the plasma level of F<sub>2</sub>-IsoPs was observed after consumption of low-fat dairy (400 mL milk/d and 200 g yogurt/d), fermented dairy (85 g cheddar cheese/d and 600 g full-cream yogurt/d) and nonfermented dairy (30 g butter/d and 70 mL cream/d) among overweight and obese subjects during a three-week period [<xref rid="B7-nutrients-13-02088" ref-type="bibr">7</xref>]. Parallel results were reported among young athletes, who had no differences in the plasma total level of F<sub>2</sub>-IsoPs between three interventions, including consumption of 500 mL/day dough (liquid yogurt), nonalcoholic beer, or chocolate milk after a 2-h intake of beverages [<xref rid="B25-nutrients-13-02088" ref-type="bibr">25</xref>]. In sum, the quantity and type of dairy product consume could modify the level of F<sub>2</sub>-IsoPs to a certain extent and specifically 5-F<sub>2t</sub>-IsoP, 8-F<sub>2t</sub>-IsoP.</p>
              <p>As expected, total energy intake was increased after HD compared to AD intervention, which included an increase in total protein, total carbohydrate and total fat, specifically SFA. Consumption of total energy and macronutrients can be associated with the plasma level of IsoPs. For example, intake of energy, total fat and SFA among women smokers was higher than in women nonsmokers, causing elevation of urinary total F<sub>2</sub>-IsoP [<xref rid="B26-nutrients-13-02088" ref-type="bibr">26</xref>]. Furthermore, no difference was indicated in the plasma level of 8-iso-PGF<sub>2α</sub> after consumption of a milkshake, with 59% of total energy as fat (including refined olive oil, palm oil, olive oil plus 4 g n-3FA), among obese and overweight adults [<xref rid="B27-nutrients-13-02088" ref-type="bibr">27</xref>]. Moreover, the Framingham cohort study showed that urinary inflammation and oxidative stress (total isoprostane) parameters were inversely associated with total protein and plant protein [<xref rid="B28-nutrients-13-02088" ref-type="bibr">28</xref>]. Further, a cross-sectional study on healthy youth with weight stable for three months and an isocaloric diet (50% carbohydrate, 30% fat, 20% protein), reported no association between urinary 15-F<sub>2t</sub>-IsoP and basal carbohydrate and lipid oxidation rate [<xref rid="B29-nutrients-13-02088" ref-type="bibr">29</xref>]. Contrary to the current study, no differences were demonstrated in consumption of total energy, carbohydrate, protein and fat between different quartiles of F<sub>2</sub>-isoP in a cross-sectional study among postmenopausal women [<xref rid="B30-nutrients-13-02088" ref-type="bibr">30</xref>]. In sum, IsoPs levels can be associated positively with the intake of fat, SFA, and total energy as demonstrated in previous studies while protein intake can reduce the urinary or plasma levels of isoPs and oxidative stress.</p>
              <p>The results indicate a positive correlation between 15-F<sub>2t</sub>-IsoP and FBG after AD intervention. Similarly, our research group previously demonstrated that higher plasma 15-F<sub>2<italic>t</italic></sub>-IsoP (up to 67%) in diabetic than nondiabetic pregnant women without any difference in the level of PUFA (n-6) and AA, while the plasma level of EPA and DHA were lower in diabetic than normoglycemia pregnant women [<xref rid="B24-nutrients-13-02088" ref-type="bibr">24</xref>]. Moreover, the plasma level of 15-F<sub>2<italic>t</italic></sub>-IsoP, was higher in prediabetic patients compared to individuals with normal glucose tolerance [<xref rid="B31-nutrients-13-02088" ref-type="bibr">31</xref>]. The plasma level of 15-F<sub>2<italic>t</italic></sub>-IsoP was even higher among T2D patients than prediabetic [<xref rid="B32-nutrients-13-02088" ref-type="bibr">32</xref>] patients, with a negative correlation between 8-iso-PGF<sub>2α</sub> and HbA<sub>1C</sub> [<xref rid="B31-nutrients-13-02088" ref-type="bibr">31</xref>]. Further, a recent cohort study among the German population indicated that urinary 15-F<sub>2<italic>t</italic></sub>-IsoP levels were positively associated with the development of T2D (increase of HbA<sub>1C</sub>) among elderly participants (&gt;60 years), especially of individuals between 65 and 75 years. Similarly, the urinary levels of 15-F<sub>2<italic>t</italic></sub>-IsoP and 8-Oxo-2′-deoxyguanosine (as a biomarker of oxidative DNA damage) increased (up to 65%) and among T2D patients compared to nondiabetic controls; therefore, 15-F<sub>2<italic>t</italic></sub>-IsoP was considered as a biomarker to early prediction of T2D [<xref rid="B33-nutrients-13-02088" ref-type="bibr">33</xref>]. The current results demonstrate the role of F<sub>2</sub>-IsoP and its isomers such as 15-F<sub>2t</sub>-IsoP, 5-F<sub>2t</sub>-IsoP and 5(<italic>RS</italic>)-5-F<sub>2<italic>c</italic></sub>-IsoP may be involved in the development of T2D.</p>
              <p>The current study showed that the level of F<sub>2</sub>-IsoP was lower among women compared to men after consumption of HD compared to AD. Similar results were found in an international multicenter (Italy, Poland, and Sweden) study, with lower (estimated −8%) urinary level of 15-F<sub>2<italic>t</italic></sub>-IsoP among women than men, which may be associated with the lower lean body mass among women compared to men [<xref rid="B34-nutrients-13-02088" ref-type="bibr">34</xref>]. Moreover, urinary 15-F<sub>2<italic>t</italic></sub>-IsoP, as the major F<sub>2</sub>-IsoP generated through lipid peroxidation, was higher (52%) among overweight/obese men compared to women. In addition, the baseline level of 5-F<sub>2<italic>t</italic></sub>-IsoP was higher among women than men while, after adjusting for sex and BMI, urinary levels of 5-F<sub>2<italic>t</italic></sub>-IsoP were reduced by 20% and 27% at 12 and 18 months after intake of a 25% calorie restriction [<xref rid="B35-nutrients-13-02088" ref-type="bibr">35</xref>]. Therefore, lower levels of F<sub>2</sub>-IsoP in women than in men could be expected [<xref rid="B36-nutrients-13-02088" ref-type="bibr">36</xref>] among hyperinsulinemic women compared to men.</p>
              <p>There were strengths and limitations in the present study. Major strengths included a controlled and randomized design, inclusion of participants from both sexes, and a six-week intervention for the laboratory parameters and dietary intake throughout the study. Moreover, the short duration of the intervention (six weeks) was considered a limitation of the present study; perhaps longer studies are needed to make changes in T2D risk factors. Furthermore, FFQs under and overestimate intake of food and it are considered a low accuracy method to measure absolute nutrient values. Further, the information for the availability of dietary components such as fatty acids is not sufficient. However, FFQs can assess usual and longer-term dietary intake. In addition, future studies should investigate whether specific types of dairy intake (e.g., milk, yogurt and cheese) can modify glycemic parameters (HOMA-IR, fasting insulin, FBG and HbA1c) among prediabetic and diabetic patients. Examination of molecular and metabolic pathways should also be done to understand the modifications of antioxidant and inflammatory responses after consumption of dairy products. Moreover, participants consumed more energy after HD compared to AD, therefore, design of an isocaloric diet to examine the effect of dairy products on oxidative stress in future studies suggest is suggested.</p>
              <p>Overall, longer studies should clarify whether the optimal number of servings per day, and the type of dairy, to prevent oxidative effects among overweight and obese subjects with hyperinsulinemia.</p>
            </sec>
            <sec sec-type="conclusions" id="sec5-nutrients-13-02088">
              <title>5. Conclusions</title>
              <p>The study clearly shows that the consumption of four servings or more of dairy per day compared to two servings or less reduced the total level of F<sub>2</sub>-IsoPs and specific isomers (5-F<sub>2t</sub>-IsoP, 8-F<sub>2t</sub>-IsoP) that could serve as markers of hyperinsulinemia in the future. This phenomenon is independent of FBG, fasting insulin and HOMA-IR, that remained unchanged between AD and HD. A reduction of oxidative damage following HD may reduce or slow down T2D development. Therefore, the link between oxidative stress and insulin resistance needs to be further investigated.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>We thank Sarah O’Connor, Andréa Taschereau-Charron, Sarah Chouinard-Castonguay, Élise Cant, Valérie-Ève Julien and Camille Lambert for their help with the visits with participants.</p>
            </ack>
            <fn-group>
              <fn>
                <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <app-group>
              <app id="app1-nutrients-13-02088">
                <title>Supplementary Materials</title>
                <p>The following are available online at <uri xlink:href="https://www.mdpi.com/article/10.3390/nu13062088/s1">https://www.mdpi.com/article/10.3390/nu13062088/s1</uri>. Figure S1: flow chart of the study. Table S1: Difference in the level of “changes in the level of isoprostane in after AD intake and beginning of AD phase” and “changes in the level of isoprostane in after HD intake and beginning HD phase”. Table S2: Difference in the level of total F<sub>2</sub>-IsoPs and isomers of F<sub>2</sub>-IsoPs at the beginning of each phase including adequate-dairy (AD) and high-dairy (HD). Table S3: Correlations between glycemic parameters and F<sub>2</sub>-IsoProstanes (IsoPs) after adequate-dairy intake. Table S4: Correlations between glycemic parameters and F<sub>2</sub>-IsoProstanes (IsoPs) after high-dairy intake</p>
                <supplementary-material content-type="local-data" id="nutrients-13-02088-s001">
                  <media xlink:href="nutrients-13-02088-s001.zip">
                    <caption>
                      <p>Click here for additional data file.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </app>
            </app-group>
            <notes>
              <title>Author Contributions</title>
              <p>J.-F.B. and I.R. were involved in the conceptualization of the study and resources, J.-F.B., K.G. and J.L. were responsible of methodology, L.K. and J.-F.B. were responsible for data analyses, L.K. and J.-F.B. wrote the original draft, K.G., J.-F.B. and I.R. were involved in reviewing and editing the manuscript, J.-F.B. and I.R. were responsible for supervision and funding acquisition. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Funding</title>
              <p>This study was funded by the Canadian Institutes of Health Research (CIHR grant numbers PJT-153191 to J.-F.B. and PJT-364008 to I.R.). L.K. received a scholarship from CHU de Québec-Laval University Research Center and Fonds de Recherche du Québec-Nature et les Technologies (FRQNT); I.R. hold a Junior 2 research Scholar from the Fonds de Recherche du Québec-Santé (FRQ-S).</p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>This study was approved by the CHU de Québec-Université Laval Research Center ethics committees (permission code: 2017-3228) and was conducted according to the principles of the declaration of Helsinki. All subjects provided written informed consent. This trial protocol is registered in ClinicalTrial.gov: NCT02961179.</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>Informed consent was obtained from all subjects involved in the study.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>Data sharing is not applicable to this article.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-nutrients-13-02088">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Montuschi</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Roberts</surname>
                      <given-names>L.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Isoprostanes: Markers and mediators of oxidative stress</article-title>
                  <source>FASEB J.</source>
                  <year>2004</year>
                  <volume>18</volume>
                  <fpage>1791</fpage>
                  <lpage>1800</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.04-2330rev</pub-id>
                  <?supplied-pmid 15576482?>
                  <pub-id pub-id-type="pmid">15576482</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-nutrients-13-02088">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaviarasan</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Muniandy</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Qvist</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Ismail</surname>
                      <given-names>I.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>F2-isoprostanes as novel biomarkers for type 2 diabetes: A review</article-title>
                  <source>J. Clin. Biochem. Nutr.</source>
                  <year>2009</year>
                  <volume>45</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.3164/jcbn.08-266</pub-id>
                  <?supplied-pmid 19590700?>
                  <pub-id pub-id-type="pmid">19590700</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-nutrients-13-02088">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brien</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Berthiaume</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Rudkowska</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Julien</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bilodeau</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Placental dimethyl acetal fatty acid derivatives are elevated in preeclampsia</article-title>
                  <source>Placenta</source>
                  <year>2017</year>
                  <volume>51</volume>
                  <fpage>82</fpage>
                  <lpage>88</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.placenta.2017.01.129</pub-id>
                  <pub-id pub-id-type="pmid">28292473</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-nutrients-13-02088">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Milne</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Musiek</surname>
                      <given-names>E.S.</given-names>
                    </name>
                    <name>
                      <surname>Morrow</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>F2-isoprostanes as markers of oxidative stress in vivo: An overview</article-title>
                  <source>Biomark</source>
                  <year>2005</year>
                  <volume>10</volume>
                  <fpage>10</fpage>
                  <lpage>23</lpage>
                  <pub-id pub-id-type="doi">10.1080/13547500500216546</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-nutrients-13-02088">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zemel</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Sobhani</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>2010</year>
                  <volume>91</volume>
                  <fpage>16</fpage>
                  <lpage>22</lpage>
                  <pub-id pub-id-type="doi">10.3945/ajcn.2009.28468</pub-id>
                  <pub-id pub-id-type="pmid">19889829</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-nutrients-13-02088">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Michaëlsson</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Wolk</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Langenskiöld</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Basu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Lemming</surname>
                      <given-names>E.W.</given-names>
                    </name>
                    <name>
                      <surname>Melhus</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Byberg</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Milk intake and risk of mortality and fractures in women and men: Cohort studies</article-title>
                  <source>BMJ</source>
                  <year>2014</year>
                  <volume>349</volume>
                  <fpage>g6015</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmj.g6015</pub-id>
                  <?supplied-pmid 25352269?>
                  <pub-id pub-id-type="pmid">25352269</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-nutrients-13-02088">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nestel</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Mellett</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Pally</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Barlow</surname>
                      <given-names>C.K.</given-names>
                    </name>
                    <name>
                      <surname>Croft</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Mori</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Meikle</surname>
                      <given-names>P.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults</article-title>
                  <source>Br. J. Nutr.</source>
                  <year>2013</year>
                  <volume>110</volume>
                  <fpage>2242</fpage>
                  <lpage>2249</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0007114513001621</pub-id>
                  <pub-id pub-id-type="pmid">23756569</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-nutrients-13-02088">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stancliffe</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Thorpe</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Zemel</surname>
                      <given-names>M.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dairy attentuates oxidative and inflammatory stress in metabolic syndrome</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>2011</year>
                  <volume>94</volume>
                  <fpage>422</fpage>
                  <lpage>430</lpage>
                  <pub-id pub-id-type="doi">10.3945/ajcn.111.013342</pub-id>
                  <pub-id pub-id-type="pmid">21715516</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-nutrients-13-02088">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wennersberg</surname>
                      <given-names>M.H.</given-names>
                    </name>
                    <name>
                      <surname>Smedman</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Turpeinen</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Retterstøl</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Tengblad</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Lipre</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Aro</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Mutanen</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Seljeflot</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Basu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Dairy products and metabolic effects in overweight men and women: Results from a 6-mo intervention study</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>2009</year>
                  <volume>90</volume>
                  <fpage>960</fpage>
                  <lpage>968</lpage>
                  <pub-id pub-id-type="doi">10.3945/ajcn.2009.27664</pub-id>
                  <pub-id pub-id-type="pmid">19710195</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-nutrients-13-02088">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>O’Connor</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Julien</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Weisnagel</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Gagnon</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Rudkowska</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of a High Intake of Dairy Product on Insulin Sensitivity in Hyperinsulinemic Adults: A Crossover Randomized Controlled Trial</article-title>
                  <source>Curr. Dev. Nutr.</source>
                  <year>2019</year>
                  <volume>3</volume>
                  <fpage>nzz083</fpage>
                  <pub-id pub-id-type="doi">10.1093/cdn/nzz083</pub-id>
                  <pub-id pub-id-type="pmid">31453424</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-nutrients-13-02088">
                <label>11.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Canada</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <source>Eating Well with Canada’s Food Guide: A Resource for Educators and Communicators</source>
                  <publisher-name>Health Canada</publisher-name>
                  <publisher-loc>Ottawa, ON, Canada</publisher-loc>
                  <year>2011</year>
                </element-citation>
              </ref>
              <ref id="B12-nutrients-13-02088">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goulet</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Nadeau</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lapointe</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Lamarche</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Lemieux</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women</article-title>
                  <source>Nutr. J.</source>
                  <year>2004</year>
                  <volume>3</volume>
                  <fpage>13</fpage>
                  <pub-id pub-id-type="doi">10.1186/1475-2891-3-13</pub-id>
                  <pub-id pub-id-type="pmid">15363100</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-nutrients-13-02088">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Passey</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Gillum</surname>
                      <given-names>R.L.</given-names>
                    </name>
                    <name>
                      <surname>Fuller</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Urry</surname>
                      <given-names>F.M.</given-names>
                    </name>
                    <name>
                      <surname>Giles</surname>
                      <given-names>M.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974)</article-title>
                  <source>Clin. Chem.</source>
                  <year>1977</year>
                  <volume>23</volume>
                  <fpage>131</fpage>
                  <lpage>139</lpage>
                  <pub-id pub-id-type="doi">10.1093/clinchem/23.1.131</pub-id>
                  <?supplied-pmid 832363?>
                  <pub-id pub-id-type="pmid">832363</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-nutrients-13-02088">
                <label>14.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kirk</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Othmer Donald</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Standen</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Scott</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <source>Encyclopedia of Chemical Technology</source>
                  <publisher-name>The Interscience Encyclopedia, Inc.</publisher-name>
                  <publisher-loc>New York, NY, USA</publisher-loc>
                  <year>1947</year>
                  <volume>Volume 1</volume>
                </element-citation>
              </ref>
              <ref id="B15-nutrients-13-02088">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Matthews</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hosker</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Rudenski</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Naylor</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Treacher</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Turner</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man</article-title>
                  <source>Diabetologia</source>
                  <year>1985</year>
                  <volume>28</volume>
                  <fpage>412</fpage>
                  <lpage>419</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF00280883</pub-id>
                  <pub-id pub-id-type="pmid">3899825</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-nutrients-13-02088">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McNamara</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Schaefer</surname>
                      <given-names>E.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions</article-title>
                  <source>Clin. Chim. Acta</source>
                  <year>1987</year>
                  <volume>166</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1016/0009-8981(87)90188-4</pub-id>
                  <pub-id pub-id-type="pmid">3608193</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-nutrients-13-02088">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Burstein</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Samaille</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>On a rapid determination of the cholesterol bound to the serum alpha-and beta-lipoproteins</article-title>
                  <source>Clin. Chim. Acta</source>
                  <year>1960</year>
                  <volume>5</volume>
                  <fpage>609</fpage>
                  <pub-id pub-id-type="doi">10.1016/0009-8981(60)90075-9</pub-id>
                  <pub-id pub-id-type="pmid">13806309</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-nutrients-13-02088">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ash</surname>
                      <given-names>K.O.</given-names>
                    </name>
                    <name>
                      <surname>Hentschel</surname>
                      <given-names>W.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>High-density lipoproteins estimated by an enzymatic cholesterol procedure, with a centrifugal analyzer</article-title>
                  <source>Clin. Chem.</source>
                  <year>1978</year>
                  <volume>24</volume>
                  <fpage>2180</fpage>
                  <lpage>2184</lpage>
                  <pub-id pub-id-type="doi">10.1093/clinchem/24.12.2180</pub-id>
                  <pub-id pub-id-type="pmid">214257</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-nutrients-13-02088">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Albers</surname>
                      <given-names>J.J.</given-names>
                    </name>
                    <name>
                      <surname>Warnick</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Wiebe</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>King</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Steiner</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Breckenridge</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Chow</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kuba</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Weidman</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein</article-title>
                  <source>Clin. Chem.</source>
                  <year>1978</year>
                  <volume>24</volume>
                  <fpage>853</fpage>
                  <lpage>856</lpage>
                  <pub-id pub-id-type="doi">10.1093/clinchem/24.6.853</pub-id>
                  <?supplied-pmid 207461?>
                  <pub-id pub-id-type="pmid">207461</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-nutrients-13-02088">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Friedewald</surname>
                      <given-names>W.T.</given-names>
                    </name>
                    <name>
                      <surname>Levy</surname>
                      <given-names>R.I.</given-names>
                    </name>
                    <name>
                      <surname>Fredrickson</surname>
                      <given-names>D.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title>
                  <source>Clin. Chem.</source>
                  <year>1972</year>
                  <volume>18</volume>
                  <fpage>499</fpage>
                  <lpage>502</lpage>
                  <pub-id pub-id-type="doi">10.1093/clinchem/18.6.499</pub-id>
                  <pub-id pub-id-type="pmid">4337382</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-nutrients-13-02088">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nayak</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Pattabiraman</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>A new colorimetric method for the estimation of glycosylated hemoglobin</article-title>
                  <source>Clin. Chim. Acta</source>
                  <year>1981</year>
                  <volume>109</volume>
                  <fpage>267</fpage>
                  <lpage>274</lpage>
                  <pub-id pub-id-type="doi">10.1016/0009-8981(81)90312-0</pub-id>
                  <pub-id pub-id-type="pmid">7226519</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-nutrients-13-02088">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Da Silva</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Julien</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bilodeau</surname>
                      <given-names>J.-F.</given-names>
                    </name>
                    <name>
                      <surname>Barbier</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Rudkowska</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Trans fatty acids suppress TNF-α-induced inflammatory gene expression in endothelial (HUVEC) and hepatocellular carcinoma (HepG2) cells</article-title>
                  <source>Lipids</source>
                  <year>2017</year>
                  <volume>52</volume>
                  <fpage>315</fpage>
                  <lpage>325</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11745-017-4243-4</pub-id>
                  <pub-id pub-id-type="pmid">28315997</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-nutrients-13-02088">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bilodeau</surname>
                      <given-names>J.-F.</given-names>
                    </name>
                    <name>
                      <surname>Wei</surname>
                      <given-names>S.Q.</given-names>
                    </name>
                    <name>
                      <surname>Larose</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Greffard</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Moisan</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Audibert</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Fraser</surname>
                      <given-names>W.D.</given-names>
                    </name>
                    <name>
                      <surname>Julien</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Plasma F2-isoprostane class VI isomers at 12–18 weeks of pregnancy are associated with later occurrence of preeclampsia</article-title>
                  <source>Free Radic Biol. Med.</source>
                  <year>2015</year>
                  <volume>85</volume>
                  <fpage>282</fpage>
                  <lpage>287</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.05.012</pub-id>
                  <?supplied-pmid 25998422?>
                  <pub-id pub-id-type="pmid">25998422</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-nutrients-13-02088">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taschereau-Charron</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bilodeau</surname>
                      <given-names>J.-F.</given-names>
                    </name>
                    <name>
                      <surname>Larose</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Greffard</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Berthiaume</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Audibert</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Fraser</surname>
                      <given-names>W.D.</given-names>
                    </name>
                    <name>
                      <surname>Julien</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Rudkowska</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>F2-isoprostanes and fatty acids profile in early pregnancy complicated by pre-existing diabetes</article-title>
                  <source>Prostaglandins Leukot. Essent. Fat. Acids</source>
                  <year>2018</year>
                  <volume>135</volume>
                  <fpage>115</fpage>
                  <lpage>120</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.plefa.2018.07.008</pub-id>
                  <?supplied-pmid 30103922?>
                  <pub-id pub-id-type="pmid">30103922</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-nutrients-13-02088">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maghsoudi</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Shiranian</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Askai</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Ghaisvand</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of various kinds of beverages on stress oxidative, F2 isoprostane, serum lipid and blood glucose of elite taekwondo players</article-title>
                  <source>Iran. J. Nurs. Midwifery Res.</source>
                  <year>2016</year>
                  <volume>21</volume>
                  <fpage>470</fpage>
                  <?supplied-pmid 27904629?>
                  <pub-id pub-id-type="pmid">27904629</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-nutrients-13-02088">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tomey</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Sowers</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>McConnell</surname>
                      <given-names>D.S.</given-names>
                    </name>
                    <name>
                      <surname>Crawford</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Gold</surname>
                      <given-names>E.B.</given-names>
                    </name>
                    <name>
                      <surname>Lasley</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Randolph</surname>
                      <given-names>J.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dietary fat subgroups, zinc, and vegetable components are related to urine F2a-isoprostane concentration, a measure of oxidative stress, in midlife women</article-title>
                  <source>J. Nutr.</source>
                  <year>2007</year>
                  <volume>137</volume>
                  <fpage>2412</fpage>
                  <lpage>2419</lpage>
                  <pub-id pub-id-type="doi">10.1093/jn/137.11.2412</pub-id>
                  <?supplied-pmid 17951478?>
                  <pub-id pub-id-type="pmid">17951478</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-nutrients-13-02088">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Peairs</surname>
                      <given-names>A.D.</given-names>
                    </name>
                    <name>
                      <surname>Rankin</surname>
                      <given-names>J.W.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>Y.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of acute ingestion of different fats on oxidative stress and inflammation in overweight and obese adults</article-title>
                  <source>Nutr. J.</source>
                  <year>2011</year>
                  <volume>10</volume>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1186/1475-2891-10-122</pub-id>
                  <pub-id pub-id-type="pmid">21208446</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-nutrients-13-02088">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hruby</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Jacques</surname>
                      <given-names>P.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dietary protein and changes in biomarkers of inflammation and oxidative stress in the Framingham Heart Study Offspring Cohort</article-title>
                  <source>Curr. Dev. Nutr.</source>
                  <year>2019</year>
                  <volume>3</volume>
                  <fpage>nzz019</fpage>
                  <pub-id pub-id-type="doi">10.1093/cdn/nzz019</pub-id>
                  <pub-id pub-id-type="pmid">31037277</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-nutrients-13-02088">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Ingram</surname>
                      <given-names>K.H.</given-names>
                    </name>
                    <name>
                      <surname>Milne</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Garvey</surname>
                      <given-names>W.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>F2-Isoprostanes reflect oxidative stress correlated with lean mass and bone density but not insulin resistance</article-title>
                  <source>J. Endocr. Soc.</source>
                  <year>2017</year>
                  <volume>1</volume>
                  <fpage>436</fpage>
                  <lpage>448</lpage>
                  <pub-id pub-id-type="doi">10.1210/js.2017-00006</pub-id>
                  <pub-id pub-id-type="pmid">29264499</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-nutrients-13-02088">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arikawa</surname>
                      <given-names>A.Y.</given-names>
                    </name>
                    <name>
                      <surname>Samavat</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Gross</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kurzer</surname>
                      <given-names>M.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Plasma F2-isoprostanes are positively associated with glycemic load, but inversely associated with dietary polyunsaturated fatty acids and insoluble fiber in postmenopausal women</article-title>
                  <source>J. Nutr.</source>
                  <year>2017</year>
                  <volume>147</volume>
                  <fpage>1693</fpage>
                  <lpage>1699</lpage>
                  <pub-id pub-id-type="pmid">28747487</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-nutrients-13-02088">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kant</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Akış</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Calan</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Arkan</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Bayraktar</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Dizdaroglu</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>İşlekel</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Elevated urinary levels of 8-oxo-2′-deoxyguanosine,(5′ R)-and (5′ S)-8, 5′-cyclo-2′-deoxyadenosines, and 8-iso-prostaglandin F2α as potential biomarkers of oxidative stress in patients with prediabetes</article-title>
                  <source>DNA Repair</source>
                  <year>2016</year>
                  <volume>48</volume>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.dnarep.2016.09.004</pub-id>
                  <pub-id pub-id-type="pmid">27769710</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-nutrients-13-02088">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Que</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Correlation of the plasma levels of soluble RAGE and endogenous secretory RAGE with oxidative stress in pre-diabetic patients</article-title>
                  <source>J. Diabetes Complicat.</source>
                  <year>2015</year>
                  <volume>29</volume>
                  <fpage>422</fpage>
                  <lpage>426</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jdiacomp.2014.12.007</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-nutrients-13-02088">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mukhtar</surname>
                      <given-names>M.H.</given-names>
                    </name>
                    <name>
                      <surname>El-Emshaty</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <name>
                      <surname>Alamodi</surname>
                      <given-names>H.S.</given-names>
                    </name>
                    <name>
                      <surname>Nasif</surname>
                      <given-names>W.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Activity of Serum 8-Iso-Prostaglandin F2α as Oxidative Stress Marker in Patients with Diabetes Mellitus Type 2 and Associated Dyslipidemic Hyperglycemia</article-title>
                  <source>Int. J. Diabetes Mellit</source>
                  <year>2016</year>
                  <volume>6</volume>
                  <fpage>318</fpage>
                  <pub-id pub-id-type="doi">10.4236/jdm.2016.64033</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-nutrients-13-02088">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Basu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Helmersson</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Jarosinska</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Sällsten</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Mazzolai</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Barregård</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulatory factors of basal F2-isoprostane formation: Population, age, gender and smoking habits in humans</article-title>
                  <source>Free Radic. Res.</source>
                  <year>2009</year>
                  <volume>43</volume>
                  <fpage>85</fpage>
                  <lpage>91</lpage>
                  <pub-id pub-id-type="doi">10.1080/10715760802610851</pub-id>
                  <?supplied-pmid 19085196?>
                  <pub-id pub-id-type="pmid">19085196</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-nutrients-13-02088">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Il’yasova</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Fontana</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Bhapkar</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pieper</surname>
                      <given-names>C.F.</given-names>
                    </name>
                    <name>
                      <surname>Spasojevic</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Redman</surname>
                      <given-names>L.M.</given-names>
                    </name>
                    <name>
                      <surname>Das</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Huffman</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Kraus</surname>
                      <given-names>W.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of 2 years of caloric restriction on oxidative status assessed by urinary F2-isoprostanes: The CALERIE 2 randomized clinical trial</article-title>
                  <source>Aging Cell</source>
                  <year>2018</year>
                  <volume>17</volume>
                  <fpage>e12719</fpage>
                  <pub-id pub-id-type="doi">10.1111/acel.12719</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-nutrients-13-02088">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Varghese</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Singer</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Gender and sex differences in adipose tissue</article-title>
                  <source>Curr. Diab. Rep.</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11892-018-1031-3</pub-id>
                  <pub-id pub-id-type="pmid">29362940</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="nutrients-13-02088-f001" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Plasma levels of F<sub>2</sub>-IsoProstane (F<sub>2</sub>-IsoPs) (ng/mL) in response to adequate-dairy (AD) and high-dairy diet (HD). Data are means ± SD (n = 27). * <italic>p</italic> &lt; 0.05 significant.</p>
              </caption>
              <graphic xlink:href="nutrients-13-02088-g001"/>
            </fig>
            <fig id="nutrients-13-02088-f002" orientation="portrait" position="float">
              <label>Figure 2</label>
              <caption>
                <p>Boxplot of estimated marginal means of difference in the plasma level of F2-IsoP (ng/mL) according to sex after high-dairy (HD) and adequate-dairy (AD) diet interventions. (<bold>A</bold>) levels of specific F<sub>2</sub>-IsoP isomers and (<bold>B</bold>) sums of all F<sub>2</sub>-IsoPs. Generalized linear mixed model (GLMM) analyses with two covariates (BMI and sex), repeated statements (visit).</p>
              </caption>
              <graphic xlink:href="nutrients-13-02088-g002"/>
            </fig>
            <table-wrap id="nutrients-13-02088-t001" orientation="portrait" position="float">
              <object-id pub-id-type="pii">nutrients-13-02088-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Coefficient estimates from GLMM analyses for main characteristic of subjects at the end of each phase following adequate dairy product intake (AD) and high dairy product intake (HD).</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Subjects Characteristics</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AD<break/>(Mean ± SD)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HD<break/>(Mean ± SD)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>f</italic>-Statistic</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coefficient<break/>(<italic>β</italic>)</th>
                    <th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic>p</italic> Value<break/>(Changes between the Group Repeated)</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BMI</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sex</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.39 ± 3.27</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.45 ± 3.20</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.58</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systolic blood pressure, mmHg</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">132.55 ± 12.63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">132.64 ± 13.10</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.16</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−7.55</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.16</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.40</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diastolic blood pressure, mmHg</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.94 ± 10.38</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76.37 ± 8.71</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.14</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.37</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.13</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.14</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fasting blood glucose, mmol/L</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.29 ± 0.57</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.31 ± 0.59</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.22</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.11</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.99</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fasting blood insulin, pmol/L</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">124.34 ± 70.81</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129.86 ± 73.59</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.52</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−13.71</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.93</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.39</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insulin resistance, HOMA-IR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.20 ± 3.80</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.19 ± 3.35</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.42</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.28</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.66</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.26</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HDL, mmol/L</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08 ± 0.24</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.09 ± 0.26</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.11</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.53</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LDL, mmol/L</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.50 ± 0.92</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.59 ± 0.96</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.054</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.36</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TG, mmol/L</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.40 ± 0.63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.49 ± 0.72</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.34</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.55</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.49</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TC, mmol/L</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.35 ± 1.06</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.47 ± 1.12</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.07</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.90</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.80</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04 *</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Values are means ± SDs (n = 27). Differences between groups after six weeks were analyzed using a generalized linear mixed model (GLMM) with intervention (AD; ≤2 servings/day of dairy products, HD; ≥4 servings/day of dairy products), sequence (AD/HD, HD/AD), intervention * sequence (carryover effect) as fixed attributes adjusted for sex and BMI with visits (V1, V2) as the repeated statement. HOMA-IR, homeostatic model assessment of insulin resistance; HDL, high-density lipoproteins; LDL, low-density lipoproteins; TG, triglycerides; TC, total cholesterol; * <italic>p</italic> &lt; 0.05. is significant in the legend of table.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="nutrients-13-02088-t002" orientation="portrait" position="float">
              <object-id pub-id-type="pii">nutrients-13-02088-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Coefficient estimates from GLMM analyses for dietary intake at the end of each phase following adequate dairy product intake (AD) and high dairy product intake (HD) in subjects with hyperinsulinemia.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dietary Intake</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AD<break/>(Mean ± SD)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HD<break/>(Mean ± SD)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>f</italic>-Statistic</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coefficient<break/>(<italic>β</italic>)</th>
                    <th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic>p</italic> Value<break/>(Changes between the Group Repeated)</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BMI</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sex</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total energy intake (kcal/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2097.88 ± 761.73</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2438.66 ± 887.63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.15</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−292.07</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.18</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total carbohydrate intake (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">236.62 ± 95.56</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">273.62 ± 109.27</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.43</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−33.29</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.34</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total protein<break/>intake (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.51 ± 33.15</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">116.48 ± 35.64</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.13</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−21.65</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.83</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total fat intake (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84.13 ± 33.15</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.06 ± 38.84</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.58</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−8.75</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.09</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saturated fatty acids (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.76 ± 12.63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.73 ± 16.62</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.80</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−8.56</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.007 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyunsaturated fatty acids (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.04 ± 5.82</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.15 ± 6.10</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.29</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.72</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.31</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.19</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monounsaturated fatty acids (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.35 ± 14.02</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.91 ± 15.01</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.35</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−1.69</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.52</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.10</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arachidonic acid (AA) (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.13 ± 0.06</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 ± 0.05</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.62</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.01</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.24</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.18</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eicosapentaenoic acid (EPA) (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.21 ± 0.29</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.19 ± 0.28</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.47</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.60</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.84</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.48</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Docosahexaenoic acid (DHA) (g/d)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.23 ± 0.26</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.21 ± 0.22</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.62</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.63</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.76</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.51</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Values are means ± SDs (n = 27.). Differences between groups after six weeks were analyzed using a generalized linear mixed model (GLMM) with intervention (AD; ≤2 servings/day of dairy products, HD; ≥4 servings/day of dairy products), sequence (AD/HD, HD/AD), intervention * sequence (carryover effect) as fixed attributes adjusted for sex and BMI with visits (V1, V2) as the repeated statement. Dietary intake was extracted from food frequency questionnaire (FFQ). * <italic>p</italic> &lt; 0.05 is significant in the legend of table.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="nutrients-13-02088-t003" orientation="portrait" position="float">
              <object-id pub-id-type="pii">nutrients-13-02088-t003_Table 3</object-id>
              <label>Table 3</label>
              <caption>
                <p>Coefficient estimates from GLMM analyses for F<sub>2</sub>-Isoprostane isomers following adequate dairy product intake (AD) and high dairy product intake (HD) in subjects with hyperinsulinemia.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Isoprostanes (IsoPs)<break/>(ng/mL)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>f</italic>-Statistic</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coefficient<break/>(<italic>β</italic>)</th>
                    <th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic>p</italic> Value<break/>(Changes between the Group Repeated)</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BMI</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sex</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5(<italic>RS</italic>)-5-F<sub>2<bold><italic>c</italic></bold></sub>-IsoP</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.328</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.061</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.255</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.677</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.001 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5-<italic>epi</italic>-5-F<sub>2<bold><italic>t</italic></bold></sub>-IsoP</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.520</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">−0.008</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.119</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.571</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.001 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5-F<sub>2<bold><italic>t</italic></bold></sub>-IsoP</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">11.215</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.023</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.002 *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.090</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8-F<sub>2<bold><italic>t</italic></bold></sub>-IsoP</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8.961</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.003</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.004 *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.259</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">15-<italic>epi</italic>-15-F<sub>2<bold><italic>t</italic></bold></sub>-IsoP</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.367</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.005</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.131</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.551</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.002 *</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">15-F<sub>2<bold><italic>t</italic></bold></sub>-IsoP</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.736</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.006</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.059</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.014 *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.900</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total F<sub>2</sub>-IsoPs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.818</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.089</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.033 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.326</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001 *</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>n = 27. Differences between groups after six weeks were analyzed using a generalized linear mixed model (GLMM) with intervention (AD, HD), sequence (AD/HD, HD/AD), intervention * sequence (carryover effect) as fixed attributes adjusted for sex and BMI with visits (V1, V2) as the repeated statement. * <italic>p</italic> &lt; 0.05 significant.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
